Abiogen Pharma acquires 97.09% stake in EffRx Pharmaceuticals

Image: Among the therapeutic areas focused by Abiogen Pharma include bone metabolism, pain treatment, as well as respiratory, metabolic (diabetes) and dermatological disorders. Credit: ep Ro from Pixabay.